---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-002577"
form_type: "8-K"
ticker: "IBO"
cik: "0001834105"
company_name: "IMPACT BIOMEDICAL INC."
filed_at: "2025-04-03T23:59:59+00:00"
generated_at: "2026-05-23T22:46:48.100573+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# DSS withdraws from $13.2M debt conversion agreement; no shares issued

## Summary
- DSS withdrew from Debt Conversion Agreement, originally dated March 24, 2025.
- Promissory Note principal balance was $13,176,477.03.
- No shares of common stock have been issued under the agreement.
- Withdrawal attributed to current market conditions.

## SEC filing metadata
- accession: 0001641172-25-002577
- form_type: 8-K
- ticker: IBO
- cik: 0001834105
- company_name: IMPACT BIOMEDICAL INC.
- filed_at: 2025-04-03T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834105/000164117225002577/0001641172-25-002577-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834105/000164117225002577/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-002577
- JSON: https://secwatch.observer/filing/0001641172-25-002577.json
- Plain text: https://secwatch.observer/filing/0001641172-25-002577.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.